Leal Health announces next-gen AI patient support platform to enable cancer treatment navigation

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Leal Health announced a first-of-its-kind GenAI single point of access technology designed to allow healthcare providers, caregivers, and cancer patients to understand diagnostics and identify personalized treatment options to support the treatment decision process.

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

An insurance-supported integrative oncology program resulted in clinically meaningful improvements in cancer-related symptoms like pain, stress, anxiety, depression, nausea, and fatigue, according to a study conducted by researchers at University Hospitals Connor Whole Health and Case Western Reserve University School of Medicine. 
Artificial intelligence is rapidly transforming biomedical research and healthcare. Large language models, foundation models, and AI agents are increasingly being deployed to assist with data interpretation, literature review, clinical decision support, and translational research. 

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login